Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy
- PMID: 24443351
- DOI: 10.1113/expphysiol.2013.077255
Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy
Abstract
New Findings What is the central question of this study? The Notch signalling pathway plays an important role in muscle regeneration, and activation of the pathway has been shown to enhance muscle regeneration in aged mice. It is unknown whether Notch activation will have a similarly beneficial effect on muscle regeneration in the context of Duchenne muscular dystrophy (DMD). What is the main finding and its importance? Although expression of Notch signalling components is altered in both mouse models of DMD and in human DMD patients, activation of the Notch signalling pathway does not confer any functional benefit on muscles from dystrophic mice, suggesting that other signalling pathways may be more fruitful targets for manipulation in treating DMD. Abstract In Duchenne muscular dystrophy (DMD), muscle damage and impaired regeneration lead to progressive muscle wasting, weakness and premature death. The Notch signalling pathway represents a central regulator of gene expression and is critical for cellular proliferation, differentiation and apoptotic signalling during all stages of embryonic muscle development. Notch activation improves muscle regeneration in aged mice, but its potential to restore regeneration and function in muscular dystrophy is unknown. We performed a comprehensive examination of several genes involved in Notch signalling in muscles from dystrophin-deficient mdx and dko (utrophin- and dystrophin-null) mice and DMD patients. A reduction of Notch1 and Hes1 mRNA in tibialis anterior muscles of dko mice and quadriceps muscles of DMD patients and a reduction of Hes1 mRNA in the diaphragm of the mdx mice were observed, with other targets being inconsistent across species. Activation and inhibition of Notch signalling, followed by measures of muscle regeneration and function, were performed in the mouse models of DMD. Notch activation had no effect on functional regeneration in C57BL/10, mdx or dko mice. Notch inhibition significantly depressed the frequency-force relationship in regenerating muscles of C57BL/10 and mdx mice after injury, indicating reduced force at each stimulation frequency, but enhanced the frequency-force relationship in muscles from dko mice. We conclude that while Notch inhibition produces slight functional defects in dystrophic muscle, Notch activation does not significantly improve muscle regeneration in murine models of muscular dystrophy. Furthermore, the inconsistent expression of Notch targets between murine models and DMD patients suggests caution when making interspecies comparisons.
Similar articles
-
Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.PLoS One. 2015 Jan 21;10(1):e0117306. doi: 10.1371/journal.pone.0117306. eCollection 2015. PLoS One. 2015. PMID: 25607927 Free PMC article.
-
Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways.Exp Physiol. 2021 Jul;106(7):1597-1611. doi: 10.1113/EP089253. Epub 2021 May 27. Exp Physiol. 2021. PMID: 33963617
-
The role of Notch signaling in muscle progenitor cell depletion and the rapid onset of histopathology in muscular dystrophy.Hum Mol Genet. 2015 May 15;24(10):2923-37. doi: 10.1093/hmg/ddv055. Epub 2015 Feb 12. Hum Mol Genet. 2015. PMID: 25678553 Free PMC article.
-
The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.Curr Top Dev Biol. 2008;84:431-53. doi: 10.1016/S0070-2153(08)00609-1. Curr Top Dev Biol. 2008. PMID: 19186250 Review.
-
Current Translational Research and Murine Models For Duchenne Muscular Dystrophy.J Neuromuscul Dis. 2016 Mar 3;3(1):29-48. doi: 10.3233/JND-150113. J Neuromuscul Dis. 2016. PMID: 27854202 Free PMC article. Review.
Cited by
-
Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle.Sci Rep. 2017 Dec 7;7(1):17142. doi: 10.1038/s41598-017-17496-7. Sci Rep. 2017. PMID: 29215066 Free PMC article.
-
Methylmercury exposure causes a persistent inhibition of myogenin expression and C2C12 myoblast differentiation.Toxicology. 2018 Jan 15;393:113-122. doi: 10.1016/j.tox.2017.11.002. Epub 2017 Nov 15. Toxicology. 2018. PMID: 29104120 Free PMC article.
-
Extracellular matrix: Dystroglycan interactions-Roles for the dystrophin-associated glycoprotein complex in skeletal tissue dynamics.Int J Exp Pathol. 2025 Mar;106(2):e12525. doi: 10.1111/iep.12525. Int J Exp Pathol. 2025. PMID: 39923120 Free PMC article. Review.
-
Biochemical and Functional Comparisons of mdx and Sgcg(-/-) Muscular Dystrophy Mouse Models.Biomed Res Int. 2015;2015:131436. doi: 10.1155/2015/131436. Epub 2015 May 3. Biomed Res Int. 2015. PMID: 26064876 Free PMC article.
-
Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.PLoS One. 2015 Jan 21;10(1):e0117306. doi: 10.1371/journal.pone.0117306. eCollection 2015. PLoS One. 2015. PMID: 25607927 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical